Search clinical trials for: Capecitabine Oral Product

Total 12477 results

Assistance Publique - Hôpitaux de Paris
CSL Behring

Completed

A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk Lymphoma (GENHIV)

HIV-1 Infection

France
Inova Health Care Services

Completed

Effects of Aromatherapy on Nausea Levels

Nausea, Postoperative

United States
National Geriatric Hospital
Ichimaru Pharcos, Co., Ltd.

Completed

Efficacy and Tolerability of Proteoglycan F in the Treatment of Knee Osteoarthritis (Proteoglycan)

Primary Osteoarthritis of Knee Nos

Vietnam
Taro Pharmaceuticals USA

Completed

A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.

Tinea Pedis

United States
Yonsei University

Completed

Clinical Validation of Nutritional Supplements Developed for Pancreaticobiliary Cancer Patients

Pancreaticobiliary Cancer

Korea, Republic of
Danone Research

Completed

Effect of Controlled Diet Combined With a Fermented Milk Product on Gas-related Symptoms (FLATBACK)

Functional Gastrointestinal Disorders

Spain
Massachusetts General Hospital
BrainCells Inc.

Completed

Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Renovo

Unknown

Adaprev in Digital Flexor Tendon Repair

Tendon Injuries

United Kingdom
ViaCyte

Terminated

A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus (VC01-103)

Type 1 Diabetes

United States
Sucampo Pharma Americas, LLC
Sucampo Pharmaceuticals, Inc.

Terminated

Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension

Portal Hypertension

United States
Fresenius Kabi
EastHORN Clinical Services in CEE; MLM Medical Labs GmbH; ALS Czech Republic,... and other collaborators

Completed

Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients (CKD)

Renal Insufficiency, Chronic

Czechia
Ege University

Completed

Developing Of A New Incontinence Care Product

Incontinence-associated Dermatitis | Nursing Care

Turkey
Petra Larmo
Tekes - The Finnish Funding Agency for Technology and Innovation; Turun Silmäexpertit... and other collaborators

Completed

Effects of a Moisturizing Product on Dry Eye and Skin (SDE)

Dry Eye Syndromes

Finland
Florida State University
University of South Florida; Colorado Business Group on Health

Completed

Depression Management at the Workplace (DMW)

Depression

United States
University of Notre Dame
Johns Hopkins University; Ministry of Health, Zambia; Macha Research Trust, Zambia

Withdrawn

Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM) (SR-M-ZM)

Malaria

Zambia
Shandong Cancer Hospital and Institute

Not yet recruiting

Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer

Metastatic Breast Cancer
Amgen

Completed

Single Ascending Dose Study of AMG 570 in Healthy Subjects

Systemic Lupus Erythematosus

United States
University of Notre Dame
Ifakara Health Institute

Withdrawn

Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Tanzania (SR-M-Tz)

Malaria

Tanzania
University of Notre Dame
Centers for Disease Control and Prevention; Kenya Medical Research Institute

Withdrawn

Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya (SR-M-KEN)

Malaria

Kenya
Coloplast A/S

Terminated

Safety and Performance Investigation of a New 1-piece Ostomy Product Compared to Standard of Care 1-piece in Subjects With Ileostomy

Ileostomy - Stoma

Netherlands
University of Virginia

Unknown

Pilot Study to Assess Tolerability and Feasibility of Oral Sulfate Solution (SUPREP) in Hospitalized Patients

Inpatient Colonoscopy | Oral Sulfate Solution | Polyethelene Glycol
University of Sao Paulo General Hospital

Unknown

The Prevstain Trial (TPT)

Varicose Veins
University of Primorska
Biovis d.o.o.

Completed

Comparative Single-dose Bioavailability Clinical Study of Different Coenzyme Q10 Products

Coenzyme Q Deficiency

Slovenia
Herbarium Laboratorio Botanico Ltda

Completed

Evaluation of Gynecological Acceptability of 3 Health Care Products

Vaginal Disease | Atrophic Vaginitis

Brazil
Ain Shams University

Completed

Granisetron Versus Ondansetron for Nausea and Vomiting in Pediatric Age Group

Nausea and Vomiting in Pediatric Age Group

Egypt
Tongji Hospital

Recruiting

Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC

Hepatocellular Carcinoma | Effects of Immunotherapy | Programmed Cell Death 1

China
University of Alabama at Birmingham

Not yet recruiting

Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer

Metastatic Breast Cancer

United States
The Netherlands Cancer Institute
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Not yet recruiting

Galunisertib Combined With Capecitabine in Advanced CRC With PM

Colorectal Cancer Metastatic | Peritoneal Carcinomatosis

Netherlands
Beijing Friendship Hospital

Recruiting

A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous Chemotherapy

Unresectable Metastatic Colorectal Cancer

China
Processa Pharmaceuticals

Active, not recruiting

A Study of the Safety and PK of PCS6422 (Eniluracil) With Capecitabine in Patients With Advanced, Refractory GI Tract Tumors

Advanced Cancer | Refractory Cancer | Tumor Gastric

United States
German Breast Group

Completed

Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer (PazoX)

Metastatic Breast Cancer

Germany
Odonate Therapeutics, Inc.

Terminated

Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC (CONTESSA)

Breast Cancer

Korea, Republic of, United States, Spain, Canada, Singapore, Taiwan, Australia, Belgium, Thailand, Hungary, Germany, United Kingdom, France, Ukraine, Austria, Czechia, Italy, Poland, Russian Federation
Taiho Oncology, Inc.
Quintiles, Inc.

Completed

A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors

Neoplasms

United States
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

A Bioequivalence Study of Capecitabine Tablets

Metastatic Breast Cancer or Metastatic Colorectal Cancer

China
Thomas Jefferson University
AMAG Pharmaceuticals, Inc.

Recruiting

IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding

Anemia, Iron Deficiency | Heavy Menstrual Bleeding

United States
Shanghai General Hospital, Shanghai Jiao Tong University...

Not yet recruiting

Study of Fuquinitinib Combined With Capecitabine First-line Maintenance in the Treatment of Metastatic Colorectal Cancer

Colorectal Carcinoma
Fudan University

Not yet recruiting

Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy

Colorectal Cancer | Colorectal Cancer Stage IV
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
University of Rochester

Recruiting

Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling

Breast Cancer

United States
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC

Esophageal Squamous Cell Carcinoma

China
Sanofi

Completed

Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer

Cancer | Breast Cancer

United States, France
Cancer Institute and Hospital, Chinese Academy...

Unknown

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

Metastatic Breast Cancer

China
Alaunos Therapeutics

Unknown

Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors

Advanced Solid Tumors

United States
Peking University Cancer Hospital & Institute
Roche Pharma AG

Unknown

Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis

Gastric Cancer

China
National Cancer Center, Korea

Unknown

S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer

Stomach Neoplasms

Korea, Republic of
Aga Khan University

Completed

Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC) (HCC-CAP)

Carcinoma, Hepatocellular

Pakistan
James A. Haley Veterans Administration Hospital
Hoffmann-La Roche

Terminated

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma

Cancer of Liver

United States
Coloplast A/S

Completed

Investigation of Two Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy and Colostomy

Ileostomy - Stoma | Colostomy - Stoma

Denmark
Asan Medical Center
Bayer

Completed

Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE

Effects of Chemotherapy | Malignant Neoplasm of Stomach

Korea, Republic of
Dutch Colorectal Cancer Group
Sanofi; Hoffmann-La Roche; Koningin Wilhelmina Fonds

Completed

Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma

Advanced Colorectal Cancer

Search clinical trials for: Capecitabine Oral Product

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations